536 related articles for article (PubMed ID: 25688243)
1. Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challenges.
Vela M; Aris M; Llorente M; Garcia-Sanz JA; Kremer L
Front Immunol; 2015; 6():12. PubMed ID: 25688243
[TBL] [Abstract][Full Text] [Related]
2. CCR4 and its ligands: from bench to bedside.
Yoshie O; Matsushima K
Int Immunol; 2015 Jan; 27(1):11-20. PubMed ID: 25087232
[TBL] [Abstract][Full Text] [Related]
3. Chemokine and chemokine receptor patterns in patients with benign and malignant salivary gland tumors: a distinct role for CCR7.
Haghshenas MR; Ashraf MJ; Khademi B; Ghaderi A; Erfani N; Razmkhah M
Eur Cytokine Netw; 2017 Mar; 28(1):27-35. PubMed ID: 28840842
[TBL] [Abstract][Full Text] [Related]
4. The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells.
Zabel BA; Lewén S; Berahovich RD; Jaén JC; Schall TJ
Mol Cancer; 2011 Jun; 10():73. PubMed ID: 21672222
[TBL] [Abstract][Full Text] [Related]
5. CCR4 as a Therapeutic Target for Cancer Immunotherapy.
Yoshie O
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771703
[TBL] [Abstract][Full Text] [Related]
6. In situ leukemic plasmacytoid dendritic cells pattern of chemokine receptors expression and in vitro migratory response.
Bendriss-Vermare N; Chaperot L; Peoc'h M; Vanbervliet B; Jacob MC; Briere F; Bensa JC; Caux C; Plumas J
Leukemia; 2004 Sep; 18(9):1491-8. PubMed ID: 15284853
[TBL] [Abstract][Full Text] [Related]
7. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
[TBL] [Abstract][Full Text] [Related]
8. Survey of chemokine receptor expression reveals frequent co-expression of skin-homing CCR4 and CCR10 in adult T-cell leukemia/lymphoma.
Harasawa H; Yamada Y; Hieshima K; Jin Z; Nakayama T; Yoshie O; Shimizu K; Hasegawa H; Hayashi T; Imaizumi Y; Ikeda S; Soda H; Soda H; Atogami S; Takasaki Y; Tsukasaki K; Tomonaga M; Murata K; Sugahara K; Tsuruda K; Kamihira S
Leuk Lymphoma; 2006 Oct; 47(10):2163-73. PubMed ID: 17071491
[TBL] [Abstract][Full Text] [Related]
9. Production of thymus and activation-regulated chemokine and macrophage-derived chemokine by CCR4+ adult T-cell leukemia cells.
Shimauchi T; Imai S; Hino R; Tokura Y
Clin Cancer Res; 2005 Mar; 11(6):2427-35. PubMed ID: 15788694
[TBL] [Abstract][Full Text] [Related]
10. Mogamulizumab and the treatment of CCR4-positive T-cell lymphomas.
Remer M; Al-Shamkhani A; Glennie M; Johnson P
Immunotherapy; 2014; 6(11):1187-206. PubMed ID: 25496334
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of chemokine receptor antagonists.
Miao M; De Clercq E; Li G
Expert Opin Drug Metab Toxicol; 2020 Jan; 16(1):11-30. PubMed ID: 31903790
[No Abstract] [Full Text] [Related]
12. Mogamulizumab: An Anti-CC Chemokine Receptor 4 Antibody for T-Cell Lymphomas.
Moore DC; Elmes JB; Shibu PA; Larck C; Park SI
Ann Pharmacother; 2020 Apr; 54(4):371-379. PubMed ID: 31648540
[No Abstract] [Full Text] [Related]
13. Expression and function of chemokine receptors on human thymocytes: implications for infection by human immunodeficiency virus type 1.
Taylor JR; Kimbrell KC; Scoggins R; Delaney M; Wu L; Camerini D
J Virol; 2001 Sep; 75(18):8752-60. PubMed ID: 11507220
[TBL] [Abstract][Full Text] [Related]
14. Serum CCL22 levels decreased in parallel with disease activity in CCR4-positive mycosis fungoides treated with mogamulizumab.
Ohuchi K; Fujimura T; Lyu C; Amagai R; Muto Y; Aiba S
Dermatol Ther; 2020 Nov; 33(6):e14099. PubMed ID: 32725764
[TBL] [Abstract][Full Text] [Related]
15. Increased chemokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells.
Hasegawa H; Nomura T; Kohno M; Tateishi N; Suzuki Y; Maeda N; Fujisawa R; Yoshie O; Fujita S
Blood; 2000 Jan; 95(1):30-8. PubMed ID: 10607681
[TBL] [Abstract][Full Text] [Related]
16. [Anti-CCR4 mAb and regulatory T cells].
Kurose K; Ohue Y; Oka M
Gan To Kagaku Ryoho; 2013 Sep; 40(9):1150-5. PubMed ID: 24047773
[TBL] [Abstract][Full Text] [Related]
17. CXC chemokine receptor 3 and CC chemokine receptor 4 expression in T-cell and NK-cell lymphomas with special reference to clinicopathological significance for peripheral T-cell lymphoma, unspecified.
Ishida T; Inagaki H; Utsunomiya A; Takatsuka Y; Komatsu H; Iida S; Takeuchi G; Eimoto T; Nakamura S; Ueda R
Clin Cancer Res; 2004 Aug; 10(16):5494-500. PubMed ID: 15328188
[TBL] [Abstract][Full Text] [Related]
18. CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma.
Kumai T; Nagato T; Kobayashi H; Komabayashi Y; Ueda S; Kishibe K; Ohkuri T; Takahara M; Celis E; Harabuchi Y
Cancer Immunol Immunother; 2015 Jun; 64(6):697-705. PubMed ID: 25754123
[TBL] [Abstract][Full Text] [Related]
19. The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-Cell leukemia/lymphoma.
Ishida T; Iida S; Akatsuka Y; Ishii T; Miyazaki M; Komatsu H; Inagaki H; Okada N; Fujita T; Shitara K; Akinaga S; Takahashi T; Utsunomiya A; Ueda R
Clin Cancer Res; 2004 Nov; 10(22):7529-39. PubMed ID: 15569983
[TBL] [Abstract][Full Text] [Related]
20. [mRNA expression of chemokine receptors in hepatic and pancreatic tumor cell lines].
Masai K; Iwashita Y; Tominaga M; Hirano S; Shibata K; Matsumoto T; Sasaki A; Ohta M; Kitano S
Gan To Kagaku Ryoho; 2004 Aug; 31(8):1261-3. PubMed ID: 15332556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
